Abstract
Acinar cell carcinoma (ACC) of the pancreas is a rare neoplasm with less aggressive behavior than ductal carcinoma. As a result, surgical resection for metastatic ACC is a therapeutic option which can result in long-term survival. There is a paucity of data describing institutional approaches to these challenging patients, and therefore, we herein describe our institution’s approach to a patient with a distal pancreatic ACC and isolated liver metastasis. The patient underwent neoadjuvant chemotherapy (FOLFIRINOX), followed by a robot-assisted distal pancreatectomy/splenectomy and non-anatomic segment 6 resection. He was discharged to home post-operative day 2. Final pathology revealed complete tumor response of the liver metastasis and a margin negative resection of the primary tumor. He remains disease free and without complications at 3 months. We highlight that combined modality therapy for metastatic ACC can yield long-term survival in selected patients. Similarly, the robotic platform enables performance of complex multivisceral resections with rapid recovery. Future research investigating precision medicine for metastatic ACC is warranted given widely variable tumor biology in this disease.
Similar content being viewed by others
References
Klimstra DS, Adsay V. Acinar neoplasms of the pancreas—a summary of 25 years of research. Semin Diagn Pathol. 2016;33:307–18.
Schmidt CM, Matos JM, Bentrem DJ, et al. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008;12:2078–86.
Wisnoski NC, Townsend CMJ, Nealon WH, et al. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma. Surgery. 2008;144:141–8.
Kitagami H, Kondo S, Hirano S, et al. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from pancreatic cancer registry of Japan Pancreas Society. Pancreas. 2007;35:42–6.
Glazer ES, Neill KG, Frakes JM, et al. Systematic review and case series report of acinar cell carcinoma of the pancreas. Cancer Control. 2016;23:446–54.
Wang Y, Wang S, Zhou X, et al. Acinar cell carcinoma: a report of 19 cases with a brief review of the literature. World J Surg Oncol. 2016;14:172.
Matos JM, Schmidt CM, Turrini O, et al. Pancreatic acinar cell carcinoma: a multi-institutional study. J Gastrointest Surg. 2009;13:1495–502.
Lowery MA, Klimstra DS, Shia J, et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist. 2011;16:1714–20.
Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol. 2002;20:4673–8.
Jauch SF, Morris VK, Jensen CT, et al. Multimodal approach and long-term survival in a patient with recurrent metastatic acinar cell carcinoma of the pancreas: a case report. Pancreatology. 2016;16:153–6.
Hashimoto M, Miki K, Kokudo N, et al. A long-term survivor of metastatic acinar cell carcinoma. Pancreas. 2007;34:271–2.
Armstrong MD, Von Hoff D, Barber B, Marlow LA, von Roemeling C, Cooper SJ, et al. An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development. J Cancer. 2011;2:142–52.
Sumiyoshi T, Shima Y, Okabayashi T, Kozuki A, Iwata J, Saisaka Y, et al. Long-term survival following pancreatectomy and s-1 chemotherapy for pancreatic acinar cell carcinoma with peritoneal dissemination: a case report and literature review. Medicine. 2015;94:e378.
Cananzi FCM, Jayanth A, Lorenzi B, Belgaumkar A, Mochlinski K, Sharma A, et al. “Chronic” metastatic pancreatic acinar cell carcinoma. Pancreatology. 2013;13:549–52.
Ohara Y, Oda T, Enomoto T, Hisakura K, Akashi Y, Ogawa K, et al. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report. World J Surg Oncol. 2018;16:158.
Suzuki A, Sakaguchi T, Morita Y, Oishi K, Fukumoto K, Inaba K, et al. Long-term survival after a repetitive surgical approach in a patient with acinar cell carcinoma of the pancreas and recurrent liver metastases: report of a case. Surg Today. 2010;40:679–83.
Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol. 1992;16:815–37.
Butturini G, Pisano M, Scarpa A, D’Onofrio M, Auriemma A, Bassi C. Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review. Langenbeck’s Arch Surg. 2011;396:363–9.
Seth AK, Argani P, Campbell KA, Cameron JL, Pawlik TM, Schulick RD, et al. Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature. J Gastrointest Surg. 2008;12:1061–7.
Yoo C, Kim BJ, Kim K-P, Lee J-L, Kim TW, Ryoo B-Y, et al. Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: potentially improved efficacy with oxaliplatin-containing regimen. Cancer Res Treat. 2017;49:759–65.
Chmielecki J, Hutchinson KE, Frampton GM, Chalmers ZR, Johnson A, Shi C, et al. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes. Cancer Discov. 2014;4:1398–405.
Jiao Y, Yonescu R, Offerhaus GJA, Klimstra DS, Maitra A, Eshleman JR, et al. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol. 2014;232:428–35.
La Rosa S, Sessa F, Capella C. Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology. Front Med. 2015;2:41.
Calin ML, Sadiq A, Arevalo G, Fuentes R, Flanders VL, Gupta N, et al. The first case report of robotic multivisceral resection for synchronous liver metastasis from pancreatic neuroendocrine tumor: a case report and literature review. J Laparoendosc Adv Surg Tech A. 2016;26:816–24.
Konstantinidis IT, Raoof M, Zheleva V, et al. Multivisceral robotic liver surgery: feasible and safe. J Robot Surg. 2019. https://doi.org/10.1007/s11701-019-01017-x.
Montalti R, Berardi G, Patriti A, et al. Outcomes of robotic vs laparoscopic hepatectomy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21:8441–51.
Hu L, Yao L, Li X, et al. Effectiveness and safety of robotic-assisted versus laparoscopic hepatectomy for liver neoplasms: a meta-analysis of retrospective studies. Asian J Surg. 2018;41:401–16.
Gavriilidis P, Lim C, Menahem B, et al. Robotic versus laparoscopic distal pancreatectomy—the first meta-analysis. HPB. 2016;18:567–74.
Chen PD, Wu CY, Hu RH, et al. Robotic major hepatectomy: Is there a learning curve? Surgery. 2017;161:642–9.
Efanov M, Alikhanov R, Tsvirkun V, et al. Comparative analysis of learning curve in complex robot-assisted and laparoscopic liver resection. HPB. 2017;19:818–24.
Shakir M, Boone BA, Polanco PM, et al. The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high-volume pancreatic centre. HPB. 2015;17:580–6.
Zhu P, Liao W, Ding ZY, et al. Learning curve in robot-assisted laparoscopic liver resection. J Gastrointest Surg. 2019;23:1778–877.
Acknowledgements
We would like to thank the patient, who allowed us to care for him and gave informed consent to share his story for the education of the medical community. We would also like to thank Dr. Azumi (Department of Pathology, Medstar Georgetown University Hospital) for providing histologic slides from the case.
Funding
No funding was used in the performance or description of this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Anthony Villano, Dr. Dany Barrak, Anish Jain, Dr. Pejman Radkani, Dr. Walid Chalhoub, Dr. Nadim Haddad, Dr. Emily Winslow, Dr. Thomas Fishbein, Dr. Jason Hawksworth, and Erin Meslar declare that they have no conflicts of interest.
Human rights
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 902002 kb)
Rights and permissions
About this article
Cite this article
Villano, A.M., Barrak, D., Jain, A. et al. Robot-assisted combined pancreatectomy/hepatectomy for metastatic pancreatic acinar cell carcinoma: case report and review of the literature. Clin J Gastroenterol 13, 973–980 (2020). https://doi.org/10.1007/s12328-020-01146-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-020-01146-z